The Effect of Vırtual Realıty Glasses on Heart Faılure Patıents
Effects of Breathıng Exercıses wıth Vırtual Realıty Glasses on Anxıety Levels, Sleep Qualıty and Respıratory Parameters in Heart Faılure Patıents
1 other identifier
interventional
45
1 country
1
Brief Summary
Anxiety and sleep disorders are among the most common symptoms in heart failure patients. In addition to pharmacological methods for anxiety and sleep disorders, non-pharmacological methods can also be used. Among these, anxiety and sleep disorders can be prevented with virtual reality glasses aimed at distraction. This study will be conducted to evaluate the effect of breathing exercises performed with virtual reality glasses on anxiety, sleep quality, and respiratory parameters. The study will be conducted with a total of 45 patients, 15 virtual reality glasses + breathing exercises, 15 breathing exercises, and 15 controls. Those in the virtual reality glasses + breathing exercises group will perform breathing exercises with virtual reality glasses once a day for 7 days. Those in the breathing exercises group will perform only breathing exercises once a day for 7 days. Anxiety, sleep disorders, and respiratory parameters of the patients will be examined.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable heart-failure
Started Oct 2025
Shorter than P25 for not_applicable heart-failure
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 16, 2025
CompletedFirst Posted
Study publicly available on registry
February 20, 2025
CompletedStudy Start
First participant enrolled
October 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2025
CompletedJuly 3, 2025
July 1, 2025
Same day
January 16, 2025
July 1, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Anxiety level
Turkish adaptation of the state-trait anxiety inventory short version (STAIS-5, STAIT-5). This form is a 4-point Likert type. It is an easy-to-apply inventory consisting of a total of 10 statements. As the score obtained in this form increases, the level of anxiety also increases.
Apply the morning before application and the morning 7 days after application.
Secondary Outcomes (1)
Sleep Quality
Apply the morning before application and the morning 7 days after application.
Study Arms (3)
Virtual reality glasses + breathing exercise app
EXPERIMENTALVirtual reality glasses + breathing exercise app
Breathing exercise practice
ACTIVE COMPARATORBreathing exercise practice
Kontrol
NO INTERVENTIONNo application will be made
Interventions
virtual reality glasses application
breathing exercise app
Eligibility Criteria
You may qualify if:
- years of age or older,
- Verbal communication,
- Place and time oriented,
- Without any psychiatric illness,
- Patients diagnosed with HF with NYHA class III-IV symptoms,
- Left ventricular ejection fraction ≥50% (LVEF-CF/HFpEF), between 40-49% (SEF-CF/HFmrEF), HF below 40% (DEF-CF/HFrEF),
- High levels of natriuretic peptides (BNP\>35 pg/mL and/or NTproBNP\>125 pg/mL),
- There is no deformity or diagnosis related to the musculoskeletal system that may prevent breathing exercise,
- Chronic diseases such as hypertension (Stage 1 and 2 HT) and diabetes mellitus are stable and the treatment for these diagnoses has not been changed in the last month,
- Who have not previously received respiratory exercise training and have not participated in a rehabilitation program,
- Patients who volunteer to participate in the study will be included in the study
You may not qualify if:
- Life signs are so abnormal as to preclude intervention,
- Patients with migraine, vertigo, active nausea-vomiting, headache, dizziness will not be included in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
T.C. Erciyes University Faculty of Medicine Hospitals
Kayseri, Talas, 38000, Turkey (Türkiye)
Related Publications (1)
Polikandrioti M, Goudevenos J, Michalis LK, Koutelekos J, Kyristi H, Tzialas D, Elisaf M. Factors associated with depression and anxiety of hospitalized patients with heart failure. Hellenic J Cardiol. 2015 Jan-Feb;56(1):26-35.
PMID: 25701969BACKGROUND
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Servet Kalyoncuo
ERCİYES UNIVERSITY
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Assistant
Study Record Dates
First Submitted
January 16, 2025
First Posted
February 20, 2025
Study Start
October 1, 2025
Primary Completion
October 1, 2025
Study Completion
December 30, 2025
Last Updated
July 3, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share